Capital Investment Advisors, LLC Moderna, Inc. Transaction History

Capital Investment Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 05, 2023	BUY	$118.38 - $210.04 $150,934 - $267,801	1,275 New	1,275 $229,000
Q2 2022 Jul 06, 2022	SELL	$117.13 - $176.59 $141,024 - $212,614	-1,204 Closed	0 $0
Q1 2022 Apr 13, 2022	BUY	$126.46 - $235.05 $48,307 - $89,789	382 Added 46.47%	1,204 $207,000
Q4 2021 Jan 10, 2022	BUY	$225.82 - $368.51 $24,388 - $39,799	108 Added 15.13%	822 $209,000
Q3 2021 Oct 13, 2021	BUY	$221.9 - $484.47 $158,436 - $345,911	714 New	714 $275,000

954

241M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Capital Investment Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Capital Investment Advisors, LLC with notifications on news.